

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.17021268 |
| 2 | negative regulation of erythrocyte differentiation (GO:0045647) | 4.98094162 |
| 3 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.84510008 |
| 4 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.84510008 |
| 5 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.75339493 |
| 6 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.73019743 |
| 7 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.68188245 |
| 8 | positive regulation of B cell differentiation (GO:0045579) | 4.58361740 |
| 9 | neutrophil activation involved in immune response (GO:0002283) | 4.37477756 |
| 10 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.32582766 |
| 11 | modulation by symbiont of host defense response (GO:0052031) | 4.14510958 |
| 12 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.14510958 |
| 13 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.14510958 |
| 14 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.14510958 |
| 15 | modulation by symbiont of host immune response (GO:0052553) | 4.14510958 |
| 16 | positive regulation by symbiont of host defense response (GO:0052509) | 4.14510958 |
| 17 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 4.12873195 |
| 18 | immunoglobulin mediated immune response (GO:0016064) | 4.09472704 |
| 19 | detection of other organism (GO:0098543) | 4.07023147 |
| 20 | detection of bacterium (GO:0016045) | 3.98506005 |
| 21 | cellular response to exogenous dsRNA (GO:0071360) | 3.95791378 |
| 22 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.93912146 |
| 23 | negative regulation of phagocytosis (GO:0050765) | 3.92706807 |
| 24 | regulation of B cell differentiation (GO:0045577) | 3.89998792 |
| 25 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.85657128 |
| 26 | mast cell activation (GO:0045576) | 3.78402299 |
| 27 | response to peptidoglycan (GO:0032494) | 3.72965143 |
| 28 | macrophage activation involved in immune response (GO:0002281) | 3.71251374 |
| 29 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.69939157 |
| 30 | B cell receptor signaling pathway (GO:0050853) | 3.67829737 |
| 31 | defense response to protozoan (GO:0042832) | 3.62013080 |
| 32 | respiratory burst (GO:0045730) | 3.59225941 |
| 33 | regulation of leukocyte degranulation (GO:0043300) | 3.54629691 |
| 34 | positive thymic T cell selection (GO:0045059) | 3.53111103 |
| 35 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.50678569 |
| 36 | pinocytosis (GO:0006907) | 3.50233252 |
| 37 | neutrophil mediated immunity (GO:0002446) | 3.46475487 |
| 38 | myeloid dendritic cell activation (GO:0001773) | 3.45750675 |
| 39 | negative thymic T cell selection (GO:0045060) | 3.45005535 |
| 40 | myeloid cell activation involved in immune response (GO:0002275) | 3.44438791 |
| 41 | regulation of MHC class II biosynthetic process (GO:0045346) | 3.44154061 |
| 42 | neutrophil activation (GO:0042119) | 3.41361737 |
| 43 | response to protozoan (GO:0001562) | 3.36893163 |
| 44 | positive regulation of antigen processing and presentation (GO:0002579) | 3.36886350 |
| 45 | germinal center formation (GO:0002467) | 3.30354258 |
| 46 | detection of external biotic stimulus (GO:0098581) | 3.29722372 |
| 47 | positive regulation of interferon-alpha production (GO:0032727) | 3.27828499 |
| 48 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.27004502 |
| 49 | response to muramyl dipeptide (GO:0032495) | 3.25767893 |
| 50 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.25494753 |
| 51 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.25409433 |
| 52 | negative T cell selection (GO:0043383) | 3.25264439 |
| 53 | ribosomal small subunit assembly (GO:0000028) | 3.22712029 |
| 54 | negative regulation of T cell mediated immunity (GO:0002710) | 3.22364960 |
| 55 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.21780988 |
| 56 | B cell mediated immunity (GO:0019724) | 3.20795243 |
| 57 | actin nucleation (GO:0045010) | 3.18251391 |
| 58 | cellular response to zinc ion (GO:0071294) | 3.16402851 |
| 59 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.15702570 |
| 60 | myeloid dendritic cell differentiation (GO:0043011) | 3.14803173 |
| 61 | granulocyte activation (GO:0036230) | 3.14352464 |
| 62 | cellular extravasation (GO:0045123) | 3.13809378 |
| 63 | cellular response to type I interferon (GO:0071357) | 3.13054310 |
| 64 | type I interferon signaling pathway (GO:0060337) | 3.13054310 |
| 65 | response to type I interferon (GO:0034340) | 3.11728126 |
| 66 | T cell migration (GO:0072678) | 3.09935157 |
| 67 | leukocyte aggregation (GO:0070486) | 3.09886665 |
| 68 | regulation of interferon-alpha production (GO:0032647) | 3.09670954 |
| 69 | regulation of gamma-delta T cell activation (GO:0046643) | 3.09168545 |
| 70 | response to interferon-beta (GO:0035456) | 3.08786746 |
| 71 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.08228169 |
| 72 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.06439274 |
| 73 | regulation of mast cell activation (GO:0033003) | 3.06242005 |
| 74 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.05000466 |
| 75 | positive regulation of mast cell degranulation (GO:0043306) | 3.05000466 |
| 76 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.02089261 |
| 77 | megakaryocyte development (GO:0035855) | 3.02064804 |
| 78 | cellular response to interferon-beta (GO:0035458) | 2.99958049 |
| 79 | T cell homeostasis (GO:0043029) | 2.99890784 |
| 80 | detection of biotic stimulus (GO:0009595) | 2.98639270 |
| 81 | regulation of mast cell degranulation (GO:0043304) | 2.98604763 |
| 82 | mannose metabolic process (GO:0006013) | 2.97054985 |
| 83 | myeloid leukocyte activation (GO:0002274) | 2.95244060 |
| 84 | microglial cell activation (GO:0001774) | 2.94542203 |
| 85 | mature B cell differentiation (GO:0002335) | 2.94475271 |
| 86 | T cell selection (GO:0045058) | 2.94213692 |
| 87 | positive regulation of granulocyte differentiation (GO:0030854) | 2.93972464 |
| 88 | negative regulation of granulocyte differentiation (GO:0030853) | 2.93794437 |
| 89 | definitive hemopoiesis (GO:0060216) | 2.92839766 |
| 90 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.91707261 |
| 91 | detection of molecule of bacterial origin (GO:0032490) | 2.90443357 |
| 92 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.90169216 |
| 93 | B cell homeostasis (GO:0001782) | 2.88815546 |
| 94 | regulation of antigen processing and presentation (GO:0002577) | 2.87465422 |
| 95 | regulation of regulated secretory pathway (GO:1903305) | 2.86592175 |
| 96 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.85827045 |
| 97 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.85145464 |
| 98 | thymic T cell selection (GO:0045061) | 2.84763728 |
| 99 | mature B cell differentiation involved in immune response (GO:0002313) | 2.84271062 |
| 100 | mast cell degranulation (GO:0043303) | 2.83918810 |
| 101 | mast cell activation involved in immune response (GO:0002279) | 2.83918810 |
| 102 | T-helper 1 type immune response (GO:0042088) | 2.82888727 |
| 103 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.81883544 |
| 104 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.81054076 |
| 105 | response to host immune response (GO:0052572) | 2.81054076 |
| 106 | negative regulation of cell killing (GO:0031342) | 2.80764738 |
| 107 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.80764738 |
| 108 | lymphocyte homeostasis (GO:0002260) | 2.80263394 |
| 109 | macrophage activation (GO:0042116) | 2.79763844 |
| 110 | NIK/NF-kappaB signaling (GO:0038061) | 2.79501304 |
| 111 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.78192589 |
| 112 | myeloid leukocyte mediated immunity (GO:0002444) | 2.77585450 |
| 113 | leukocyte degranulation (GO:0043299) | 2.77045650 |
| 114 | dendritic cell differentiation (GO:0097028) | 2.75325525 |
| 115 | positive T cell selection (GO:0043368) | 2.75152925 |
| 116 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.75019620 |
| 117 | positive regulation of mast cell activation (GO:0033005) | 2.74046544 |
| 118 | negative regulation of interleukin-6 production (GO:0032715) | 2.72946986 |
| 119 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.72853190 |
| 120 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.72768870 |
| 121 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.72468332 |
| 122 | positive regulation of interferon-beta production (GO:0032728) | 2.71813977 |
| 123 | leukocyte mediated cytotoxicity (GO:0001909) | 2.71740025 |
| 124 | negative regulation of innate immune response (GO:0045824) | 2.70580321 |
| 125 | negative regulation of interleukin-12 production (GO:0032695) | 2.62533541 |
| 126 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.61740514 |
| 127 | cellular response to dsRNA (GO:0071359) | 2.61564501 |
| 128 | positive regulation of B cell activation (GO:0050871) | 2.60489972 |
| 129 | negative regulation of B cell proliferation (GO:0030889) | 2.59090775 |
| 130 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.58930068 |
| 131 | response to host (GO:0075136) | 2.58930068 |
| 132 | response to host defenses (GO:0052200) | 2.58930068 |
| 133 | angiogenesis involved in wound healing (GO:0060055) | 2.57462360 |
| 134 | leukocyte homeostasis (GO:0001776) | 2.57200523 |
| 135 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 2.56346261 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.17896902 |
| 2 | E2F7_22180533_ChIP-Seq_HELA_Human | 5.02411831 |
| 3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.38357178 |
| 4 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.21609349 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.80236684 |
| 6 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.77429963 |
| 7 | SCL_19346495_ChIP-Seq_HPC-7_Human | 3.40556403 |
| 8 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.26176504 |
| 9 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 3.24575748 |
| 10 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.21500539 |
| 11 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.14469925 |
| 12 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 3.12605720 |
| 13 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.98646531 |
| 14 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.83764571 |
| 15 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.80229632 |
| 16 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.78939907 |
| 17 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.78147594 |
| 18 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.66008569 |
| 19 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.63739047 |
| 20 | MYC_22102868_ChIP-Seq_BL_Human | 2.57902893 |
| 21 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.44448212 |
| 22 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.43583163 |
| 23 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.29965886 |
| 24 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.27721730 |
| 25 | MYB_26560356_Chip-Seq_TH2_Human | 2.23898615 |
| 26 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.20438027 |
| 27 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.19477906 |
| 28 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.17874739 |
| 29 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.16850511 |
| 30 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 2.16767261 |
| 31 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.15947441 |
| 32 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.08771969 |
| 33 | MAF_26560356_Chip-Seq_TH1_Human | 2.01680876 |
| 34 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.97254259 |
| 35 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.93747529 |
| 36 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.93662140 |
| 37 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.92323412 |
| 38 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.91091771 |
| 39 | MYB_26560356_Chip-Seq_TH1_Human | 1.90032648 |
| 40 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.87868036 |
| 41 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.85159020 |
| 42 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.82488156 |
| 43 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.78300624 |
| 44 | SPI1_23127762_ChIP-Seq_K562_Human | 1.75615502 |
| 45 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.75562167 |
| 46 | UTX_26944678_Chip-Seq_JUKART_Human | 1.72642365 |
| 47 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.66877464 |
| 48 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.63535292 |
| 49 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.62558070 |
| 50 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.61190767 |
| 51 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.60951800 |
| 52 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.60905971 |
| 53 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.60877126 |
| 54 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.58939643 |
| 55 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.58091806 |
| 56 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.57806044 |
| 57 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.56168232 |
| 58 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.55175326 |
| 59 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.53220335 |
| 60 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.50921149 |
| 61 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.47845577 |
| 62 | GATA1_22025678_ChIP-Seq_K562_Human | 1.44649224 |
| 63 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.42352785 |
| 64 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.38553791 |
| 65 | GATA1_19941826_ChIP-Seq_K562_Human | 1.37392334 |
| 66 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.34712186 |
| 67 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.29855740 |
| 68 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.29506275 |
| 69 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.26711344 |
| 70 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.25522528 |
| 71 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.24987425 |
| 72 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.24946084 |
| 73 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.21802378 |
| 74 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.20588738 |
| 75 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.18991911 |
| 76 | MAF_26560356_Chip-Seq_TH2_Human | 1.18588001 |
| 77 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.17186449 |
| 78 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.16581938 |
| 79 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.16384757 |
| 80 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.15823020 |
| 81 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.14697424 |
| 82 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.13614438 |
| 83 | GATA3_26560356_Chip-Seq_TH2_Human | 1.12044118 |
| 84 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.09167047 |
| 85 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.09155796 |
| 86 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.09072597 |
| 87 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.06706333 |
| 88 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.06508799 |
| 89 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.05688615 |
| 90 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.05124342 |
| 91 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.05112025 |
| 92 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.04548627 |
| 93 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.03412604 |
| 94 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.02986194 |
| 95 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.02926454 |
| 96 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.01697785 |
| 97 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.00640816 |
| 98 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 0.99448148 |
| 99 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.99311722 |
| 100 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.97527421 |
| 101 | GATA2_19941826_ChIP-Seq_K562_Human | 0.95431382 |
| 102 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.93959741 |
| 103 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.91256352 |
| 104 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 0.90839285 |
| 105 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 0.90592577 |
| 106 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.90002135 |
| 107 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.88778537 |
| 108 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.87880400 |
| 109 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.87876006 |
| 110 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.87799956 |
| 111 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.87336938 |
| 112 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.86954819 |
| 113 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.86810584 |
| 114 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.84967290 |
| 115 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 0.84706724 |
| 116 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.84292602 |
| 117 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.83296853 |
| 118 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.82873411 |
| 119 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.82074599 |
| 120 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.81945361 |
| 121 | P68_20966046_ChIP-Seq_HELA_Human | 0.81744043 |
| 122 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.80525188 |
| 123 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 0.79641749 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 4.89589013 |
| 2 | MP0009785_altered_susceptibility_to | 3.13399747 |
| 3 | MP0003436_decreased_susceptibility_to | 3.12469180 |
| 4 | MP0005671_abnormal_response_to | 3.03083019 |
| 5 | MP0001800_abnormal_humoral_immune | 3.02011073 |
| 6 | MP0000685_abnormal_immune_system | 2.95424746 |
| 7 | MP0002419_abnormal_innate_immunity | 2.95378626 |
| 8 | MP0002396_abnormal_hematopoietic_system | 2.93675854 |
| 9 | MP0001790_abnormal_immune_system | 2.92672162 |
| 10 | MP0005387_immune_system_phenotype | 2.92672162 |
| 11 | MP0005000_abnormal_immune_tolerance | 2.89451260 |
| 12 | MP0002452_abnormal_antigen_presenting | 2.84735251 |
| 13 | MP0005025_abnormal_response_to | 2.82940404 |
| 14 | MP0002148_abnormal_hypersensitivity_rea | 2.78541858 |
| 15 | MP0002723_abnormal_immune_serum | 2.66886983 |
| 16 | MP0002420_abnormal_adaptive_immunity | 2.64290706 |
| 17 | MP0001819_abnormal_immune_cell | 2.63085168 |
| 18 | MP0003303_peritoneal_inflammation | 2.55306791 |
| 19 | MP0005464_abnormal_platelet_physiology | 2.50513121 |
| 20 | MP0002398_abnormal_bone_marrow | 2.35399385 |
| 21 | MP0000716_abnormal_immune_system | 2.17839357 |
| 22 | MP0003724_increased_susceptibility_to | 2.17136403 |
| 23 | MP0003763_abnormal_thymus_physiology | 2.14751299 |
| 24 | MP0005058_abnormal_lysosome_morphology | 2.11942932 |
| 25 | MP0005174_abnormal_tail_pigmentation | 2.09987388 |
| 26 | MP0002166_altered_tumor_susceptibility | 2.05854998 |
| 27 | MP0000689_abnormal_spleen_morphology | 2.01508753 |
| 28 | MP0004808_abnormal_hematopoietic_stem | 1.99876973 |
| 29 | MP0001853_heart_inflammation | 1.98784455 |
| 30 | MP0002405_respiratory_system_inflammati | 1.95614410 |
| 31 | MP0002722_abnormal_immune_system | 1.89785748 |
| 32 | MP0005397_hematopoietic_system_phenotyp | 1.87834981 |
| 33 | MP0001545_abnormal_hematopoietic_system | 1.87834981 |
| 34 | MP0002429_abnormal_blood_cell | 1.87296723 |
| 35 | MP0006082_CNS_inflammation | 1.82177547 |
| 36 | MP0003172_abnormal_lysosome_physiology | 1.81844786 |
| 37 | MP0000465_gastrointestinal_hemorrhage | 1.81209391 |
| 38 | MP0001845_abnormal_inflammatory_respons | 1.79604170 |
| 39 | MP0009333_abnormal_splenocyte_physiolog | 1.78895674 |
| 40 | MP0005451_abnormal_body_composition | 1.74395776 |
| 41 | MP0010155_abnormal_intestine_physiology | 1.72830353 |
| 42 | MP0002006_tumorigenesis | 1.72112682 |
| 43 | MP0009278_abnormal_bone_marrow | 1.62932241 |
| 44 | MP0001873_stomach_inflammation | 1.61107910 |
| 45 | MP0003183_abnormal_peptide_metabolism | 1.57731029 |
| 46 | MP0004510_myositis | 1.55555250 |
| 47 | MP0003300_gastrointestinal_ulcer | 1.55315468 |
| 48 | MP0000569_abnormal_digit_pigmentation | 1.51679155 |
| 49 | MP0005075_abnormal_melanosome_morpholog | 1.50188527 |
| 50 | MP0001533_abnormal_skeleton_physiology | 1.50040376 |
| 51 | MP0000703_abnormal_thymus_morphology | 1.44943847 |
| 52 | MP0000490_abnormal_crypts_of | 1.43696812 |
| 53 | MP0005310_abnormal_salivary_gland | 1.43654815 |
| 54 | MP0008469_abnormal_protein_level | 1.43256943 |
| 55 | MP0008057_abnormal_DNA_replication | 1.38358778 |
| 56 | MP0004947_skin_inflammation | 1.34315612 |
| 57 | MP0003191_abnormal_cellular_cholesterol | 1.33342839 |
| 58 | MP0008260_abnormal_autophagy | 1.32710898 |
| 59 | MP0000604_amyloidosis | 1.26325095 |
| 60 | MP0000015_abnormal_ear_pigmentation | 1.22376078 |
| 61 | MP0003866_abnormal_defecation | 1.19708346 |
| 62 | MP0000858_altered_metastatic_potential | 1.18862638 |
| 63 | MP0003448_altered_tumor_morphology | 1.18134720 |
| 64 | MP0000343_altered_response_to | 1.17962005 |
| 65 | MP0002019_abnormal_tumor_incidence | 1.01881491 |
| 66 | MP0002933_joint_inflammation | 1.01832385 |
| 67 | MP0001851_eye_inflammation | 1.01111063 |
| 68 | MP0002095_abnormal_skin_pigmentation | 0.99731515 |
| 69 | MP0009764_decreased_sensitivity_to | 0.98845403 |
| 70 | MP0010094_abnormal_chromosome_stability | 0.97134815 |
| 71 | MP0010307_abnormal_tumor_latency | 0.93702047 |
| 72 | MP0006054_spinal_hemorrhage | 0.91664648 |
| 73 | MP0004381_abnormal_hair_follicle | 0.90276110 |
| 74 | MP0002138_abnormal_hepatobiliary_system | 0.89991543 |
| 75 | MP0003690_abnormal_glial_cell | 0.89381416 |
| 76 | MP0002998_abnormal_bone_remodeling | 0.88545198 |
| 77 | MP0009840_abnormal_foam_cell | 0.88071521 |
| 78 | MP0003693_abnormal_embryo_hatching | 0.85762435 |
| 79 | MP0003077_abnormal_cell_cycle | 0.85640507 |
| 80 | MP0008007_abnormal_cellular_replicative | 0.85475150 |
| 81 | MP0003828_pulmonary_edema | 0.83732928 |
| 82 | MP0001986_abnormal_taste_sensitivity | 0.81667336 |
| 83 | MP0003806_abnormal_nucleotide_metabolis | 0.80967536 |
| 84 | MP0000371_diluted_coat_color | 0.78749219 |
| 85 | MP0002009_preneoplasia | 0.76666633 |
| 86 | MP0004883_abnormal_blood_vessel | 0.76362314 |
| 87 | MP0009763_increased_sensitivity_to | 0.75584052 |
| 88 | MP0008058_abnormal_DNA_repair | 0.74642775 |
| 89 | MP0003943_abnormal_hepatobiliary_system | 0.74332648 |
| 90 | MP0002132_abnormal_respiratory_system | 0.74305418 |
| 91 | MP0001879_abnormal_lymphatic_vessel | 0.71127049 |
| 92 | MP0008004_abnormal_stomach_pH | 0.69563200 |
| 93 | MP0000249_abnormal_blood_vessel | 0.69535781 |
| 94 | MP0002877_abnormal_melanocyte_morpholog | 0.68095802 |
| 95 | MP0005076_abnormal_cell_differentiation | 0.68060179 |
| 96 | MP0009765_abnormal_xenobiotic_induced | 0.67749762 |
| 97 | MP0000313_abnormal_cell_death | 0.66871680 |
| 98 | MP0003075_altered_response_to | 0.66046238 |
| 99 | MP0003111_abnormal_nucleus_morphology | 0.65407087 |
| 100 | MP0005166_decreased_susceptibility_to | 0.65376230 |
| 101 | MP0001663_abnormal_digestive_system | 0.64119141 |
| 102 | MP0005390_skeleton_phenotype | 0.63912882 |
| 103 | MP0005164_abnormal_response_to | 0.63843203 |
| 104 | MP0008874_decreased_physiological_sensi | 0.58400812 |
| 105 | MP0003091_abnormal_cell_migration | 0.57579918 |
| 106 | MP0003656_abnormal_erythrocyte_physiolo | 0.56983630 |
| 107 | MP0000609_abnormal_liver_physiology | 0.55176034 |
| 108 | MP0005167_abnormal_blood-brain_barrier | 0.54829938 |
| 109 | MP0003795_abnormal_bone_structure | 0.54062381 |
| 110 | MP0008873_increased_physiological_sensi | 0.53520020 |
| 111 | MP0004185_abnormal_adipocyte_glucose | 0.52804359 |
| 112 | MP0009115_abnormal_fat_cell | 0.52039987 |
| 113 | MP0003566_abnormal_cell_adhesion | 0.50561694 |
| 114 | MP0010352_gastrointestinal_tract_polyps | 0.50296658 |
| 115 | MP0003453_abnormal_keratinocyte_physiol | 0.50016014 |
| 116 | MP0002075_abnormal_coat/hair_pigmentati | 0.49846624 |
| 117 | MP0003045_fibrosis | 0.49661140 |
| 118 | MP0005647_abnormal_sex_gland | 0.49340589 |
| 119 | MP0002136_abnormal_kidney_physiology | 0.47194536 |
| 120 | MP0000598_abnormal_liver_morphology | 0.46862462 |
| 121 | MP0002928_abnormal_bile_duct | 0.46223612 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 5.81666169 |
| 2 | Recurrent bacterial skin infections (HP:0005406) | 5.30649407 |
| 3 | Eczematoid dermatitis (HP:0000976) | 4.86312996 |
| 4 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 4.84967027 |
| 5 | Recurrent viral infections (HP:0004429) | 4.80322497 |
| 6 | Panhypogammaglobulinemia (HP:0003139) | 4.58112392 |
| 7 | Recurrent fungal infections (HP:0002841) | 4.48145731 |
| 8 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.41647388 |
| 9 | Chronic mucocutaneous candidiasis (HP:0002728) | 4.34161995 |
| 10 | Recurrent cutaneous fungal infections (HP:0011370) | 4.34161995 |
| 11 | Myositis (HP:0100614) | 4.26320768 |
| 12 | Recurrent skin infections (HP:0001581) | 4.13557789 |
| 13 | Chronic otitis media (HP:0000389) | 4.12140861 |
| 14 | Agammaglobulinemia (HP:0004432) | 4.11159553 |
| 15 | Colitis (HP:0002583) | 4.04742826 |
| 16 | IgM deficiency (HP:0002850) | 4.04550285 |
| 17 | Thrombocytosis (HP:0001894) | 3.86462017 |
| 18 | Meningitis (HP:0001287) | 3.72016884 |
| 19 | Inflammation of the large intestine (HP:0002037) | 3.65690125 |
| 20 | Abnormality of macrophages (HP:0004311) | 3.64189181 |
| 21 | Mediastinal lymphadenopathy (HP:0100721) | 3.60472074 |
| 22 | Abnormality of T cell physiology (HP:0011840) | 3.56209554 |
| 23 | Gastrointestinal inflammation (HP:0004386) | 3.51193339 |
| 24 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.45371466 |
| 25 | Vacuolated lymphocytes (HP:0001922) | 3.44153229 |
| 26 | Cellulitis (HP:0100658) | 3.41818803 |
| 27 | Petechiae (HP:0000967) | 3.36098573 |
| 28 | Chronic obstructive pulmonary disease (HP:0006510) | 3.25546561 |
| 29 | Obstructive lung disease (HP:0006536) | 3.25546561 |
| 30 | Orchitis (HP:0100796) | 3.18251961 |
| 31 | Vasculitis (HP:0002633) | 3.03456958 |
| 32 | Recurrent bronchitis (HP:0002837) | 3.02124404 |
| 33 | Abnormality of T cells (HP:0002843) | 2.98667788 |
| 34 | Increased cerebral lipofuscin (HP:0011813) | 2.96960029 |
| 35 | Retrobulbar optic neuritis (HP:0100654) | 2.92019645 |
| 36 | Optic neuritis (HP:0100653) | 2.92019645 |
| 37 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.90208087 |
| 38 | Spontaneous hematomas (HP:0007420) | 2.87213829 |
| 39 | Loss of speech (HP:0002371) | 2.86203669 |
| 40 | Prolonged bleeding time (HP:0003010) | 2.82925485 |
| 41 | Encephalitis (HP:0002383) | 2.81003394 |
| 42 | Purpura (HP:0000979) | 2.78359742 |
| 43 | Gingivitis (HP:0000230) | 2.72181965 |
| 44 | Periodontitis (HP:0000704) | 2.70067468 |
| 45 | Lymphopenia (HP:0001888) | 2.66380396 |
| 46 | Systemic lupus erythematosus (HP:0002725) | 2.65127398 |
| 47 | Recurrent lower respiratory tract infections (HP:0002783) | 2.61947391 |
| 48 | Gastrointestinal infarctions (HP:0005244) | 2.61496885 |
| 49 | Epistaxis (HP:0000421) | 2.60989063 |
| 50 | Type 2 muscle fiber atrophy (HP:0003554) | 2.59873814 |
| 51 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.59507281 |
| 52 | Hepatosplenomegaly (HP:0001433) | 2.56983309 |
| 53 | Interstitial pulmonary disease (HP:0006530) | 2.55147531 |
| 54 | Abnormality of the prostate (HP:0008775) | 2.55018866 |
| 55 | Osteomyelitis (HP:0002754) | 2.54964464 |
| 56 | Muscle fiber atrophy (HP:0100295) | 2.54153065 |
| 57 | Increased serum ferritin (HP:0003281) | 2.49563448 |
| 58 | Leukocytosis (HP:0001974) | 2.48058394 |
| 59 | Eosinophilia (HP:0001880) | 2.47348876 |
| 60 | Viral hepatitis (HP:0006562) | 2.46331860 |
| 61 | Recurrent pneumonia (HP:0006532) | 2.44447577 |
| 62 | Autoimmune thrombocytopenia (HP:0001973) | 2.41298900 |
| 63 | Pustule (HP:0200039) | 2.39067200 |
| 64 | Granulocytopenia (HP:0001913) | 2.38788882 |
| 65 | Pulmonary infiltrates (HP:0002113) | 2.37298784 |
| 66 | B lymphocytopenia (HP:0010976) | 2.36933630 |
| 67 | Abnormality of B cell number (HP:0010975) | 2.36933630 |
| 68 | Increased IgM level (HP:0003496) | 2.35476088 |
| 69 | Dysostosis multiplex (HP:0000943) | 2.35326748 |
| 70 | Thyroiditis (HP:0100646) | 2.34894008 |
| 71 | Arterial thrombosis (HP:0004420) | 2.29946668 |
| 72 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.28848086 |
| 73 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.28848086 |
| 74 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.28848086 |
| 75 | Agnosia (HP:0010524) | 2.28450306 |
| 76 | Abnormal platelet function (HP:0011869) | 2.28347566 |
| 77 | Impaired platelet aggregation (HP:0003540) | 2.28347566 |
| 78 | Stomatitis (HP:0010280) | 2.27744885 |
| 79 | Gingival bleeding (HP:0000225) | 2.27225419 |
| 80 | Nasal polyposis (HP:0100582) | 2.26678562 |
| 81 | Gastrointestinal stroma tumor (HP:0100723) | 2.25645901 |
| 82 | Abnormality of the nasal mucosa (HP:0000433) | 2.24353330 |
| 83 | Chest pain (HP:0100749) | 2.23211042 |
| 84 | IgG deficiency (HP:0004315) | 2.22563816 |
| 85 | Increased IgE level (HP:0003212) | 2.22333662 |
| 86 | Autoimmune hemolytic anemia (HP:0001890) | 2.22062714 |
| 87 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.21971887 |
| 88 | Hemoptysis (HP:0002105) | 2.21060047 |
| 89 | Restrictive lung disease (HP:0002091) | 2.18976755 |
| 90 | Amyloidosis (HP:0011034) | 2.17061153 |
| 91 | Keratoconjunctivitis (HP:0001096) | 2.16388533 |
| 92 | Abnormality of iron homeostasis (HP:0011031) | 2.14679489 |
| 93 | Thoracic kyphosis (HP:0002942) | 2.14652470 |
| 94 | Abnormality of glycolipid metabolism (HP:0010969) | 2.13455840 |
| 95 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.13455840 |
| 96 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.13455840 |
| 97 | Hematochezia (HP:0002573) | 2.13445560 |
| 98 | Sepsis (HP:0100806) | 2.12783959 |
| 99 | Basal ganglia calcification (HP:0002135) | 2.12078478 |
| 100 | Abnormality of eosinophils (HP:0001879) | 2.11364686 |
| 101 | Amaurosis fugax (HP:0100576) | 2.11002219 |
| 102 | Recurrent sinusitis (HP:0011108) | 2.10716182 |
| 103 | Keratoconjunctivitis sicca (HP:0001097) | 2.09258774 |
| 104 | T lymphocytopenia (HP:0005403) | 2.09053856 |
| 105 | Aplastic anemia (HP:0001915) | 2.08589619 |
| 106 | Leukopenia (HP:0001882) | 2.07855015 |
| 107 | Disinhibition (HP:0000734) | 2.07706908 |
| 108 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.06323600 |
| 109 | Hypergammaglobulinemia (HP:0010702) | 2.06175052 |
| 110 | Neutropenia (HP:0001875) | 2.06125464 |
| 111 | Abnormality of T cell number (HP:0011839) | 2.05896273 |
| 112 | Abnormal number of erythroid precursors (HP:0012131) | 2.05398456 |
| 113 | Chronic sinusitis (HP:0011109) | 2.04610414 |
| 114 | Urticaria (HP:0001025) | 2.03728028 |
| 115 | Episodic fever (HP:0001954) | 2.02527413 |
| 116 | Pulmonary embolism (HP:0002204) | 2.01762333 |
| 117 | IgA deficiency (HP:0002720) | 1.99123556 |
| 118 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.99100620 |
| 119 | Mucopolysacchariduria (HP:0008155) | 1.99100620 |
| 120 | Hypertensive crisis (HP:0100735) | 1.98770217 |
| 121 | Lymphoma (HP:0002665) | 1.98766983 |
| 122 | Premature loss of primary teeth (HP:0006323) | 1.97822952 |
| 123 | Verrucae (HP:0200043) | 1.95010646 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 4.14478732 |
| 2 | PRPF4B | 3.62409871 |
| 3 | KIT | 3.30137094 |
| 4 | IRAK4 | 3.06560688 |
| 5 | TAOK3 | 2.95789769 |
| 6 | BLK | 2.77174199 |
| 7 | TYK2 | 2.61716819 |
| 8 | MAP3K14 | 2.42741714 |
| 9 | CSF1R | 2.29054782 |
| 10 | TBK1 | 2.24234319 |
| 11 | BTK | 2.22030103 |
| 12 | TXK | 2.15050244 |
| 13 | TEC | 2.12732900 |
| 14 | RIPK4 | 2.07508471 |
| 15 | IKBKE | 1.95651398 |
| 16 | JAK3 | 1.95054812 |
| 17 | IRAK3 | 1.93990844 |
| 18 | TGFBR2 | 1.90241311 |
| 19 | ZAP70 | 1.88706998 |
| 20 | SYK | 1.88179061 |
| 21 | FES | 1.81109065 |
| 22 | NEK9 | 1.78739595 |
| 23 | IKBKB | 1.70227144 |
| 24 | ERN1 | 1.55868365 |
| 25 | SIK2 | 1.53258767 |
| 26 | SMG1 | 1.51765631 |
| 27 | PIM2 | 1.47224980 |
| 28 | MAP2K3 | 1.45100000 |
| 29 | FLT3 | 1.41828420 |
| 30 | EEF2K | 1.41403591 |
| 31 | KDR | 1.40398111 |
| 32 | CLK1 | 1.37359972 |
| 33 | STK10 | 1.36783300 |
| 34 | JAK1 | 1.36389285 |
| 35 | HCK | 1.31026710 |
| 36 | LYN | 1.29296725 |
| 37 | FGR | 1.28913829 |
| 38 | TRIB3 | 1.25392075 |
| 39 | MAP3K3 | 1.21307840 |
| 40 | NME2 | 1.20417296 |
| 41 | LCK | 1.19502232 |
| 42 | GRK6 | 1.18378307 |
| 43 | SIK3 | 1.14949205 |
| 44 | TAOK1 | 1.13946585 |
| 45 | MAP3K13 | 1.12008286 |
| 46 | SCYL2 | 1.09872702 |
| 47 | PIM1 | 1.09378400 |
| 48 | RPS6KA4 | 1.07177987 |
| 49 | ITK | 1.06629393 |
| 50 | CDK12 | 1.05844247 |
| 51 | PKN2 | 1.03704202 |
| 52 | MAP3K1 | 1.03088452 |
| 53 | TGFBR1 | 1.03071211 |
| 54 | LRRK2 | 1.02549528 |
| 55 | CSK | 1.01881439 |
| 56 | BMPR2 | 1.01086385 |
| 57 | CHUK | 1.00345551 |
| 58 | STK4 | 0.99540207 |
| 59 | MATK | 0.94902008 |
| 60 | MAPK12 | 0.92405746 |
| 61 | EPHB1 | 0.92231888 |
| 62 | TAOK2 | 0.90020649 |
| 63 | MAP3K10 | 0.89134363 |
| 64 | GRK7 | 0.76286182 |
| 65 | CDC42BPA | 0.75276793 |
| 66 | MAPK7 | 0.74302011 |
| 67 | MARK2 | 0.74114076 |
| 68 | JAK2 | 0.72256214 |
| 69 | TNK2 | 0.71672070 |
| 70 | STK16 | 0.71603792 |
| 71 | PDPK1 | 0.68212373 |
| 72 | NLK | 0.66723912 |
| 73 | ATR | 0.64883536 |
| 74 | VRK1 | 0.62969718 |
| 75 | RPS6KA6 | 0.62818472 |
| 76 | NEK2 | 0.62262739 |
| 77 | YES1 | 0.62033931 |
| 78 | IRAK2 | 0.61400648 |
| 79 | CDK4 | 0.60794934 |
| 80 | MAP2K6 | 0.60644626 |
| 81 | MOS | 0.54104791 |
| 82 | MAPK4 | 0.53324764 |
| 83 | PAK4 | 0.52916547 |
| 84 | MAPK11 | 0.52877143 |
| 85 | TRPM7 | 0.52388234 |
| 86 | ADRBK2 | 0.51939456 |
| 87 | DYRK3 | 0.51646361 |
| 88 | MARK3 | 0.51461085 |
| 89 | RPS6KL1 | 0.50975043 |
| 90 | RPS6KC1 | 0.50975043 |
| 91 | MAP3K6 | 0.50064188 |
| 92 | EIF2AK3 | 0.49837485 |
| 93 | EIF2AK2 | 0.48581304 |
| 94 | KSR2 | 0.48561234 |
| 95 | PDK1 | 0.48125760 |
| 96 | FGFR4 | 0.47524262 |
| 97 | PRKD2 | 0.47501355 |
| 98 | FGFR3 | 0.47378377 |
| 99 | PIK3CG | 0.47017321 |
| 100 | ICK | 0.46429420 |
| 101 | CDK6 | 0.45692865 |
| 102 | MAP3K8 | 0.45200858 |
| 103 | TIE1 | 0.45117467 |
| 104 | HIPK2 | 0.44510767 |
| 105 | MAPKAPK2 | 0.43701538 |
| 106 | PASK | 0.42227046 |
| 107 | MAP3K11 | 0.41616531 |
| 108 | WEE1 | 0.40744169 |
| 109 | MAP3K12 | 0.40066763 |
| 110 | PRKCD | 0.39547071 |
| 111 | CDK7 | 0.39247502 |
| 112 | RPS6KB2 | 0.38716403 |
| 113 | CCNB1 | 0.37944445 |
| 114 | ABL1 | 0.36701412 |
| 115 | RPS6KA2 | 0.36667541 |
| 116 | FYN | 0.35952215 |
| 117 | IRAK1 | 0.34633002 |
| 118 | MAP3K7 | 0.34594554 |
| 119 | CAMK1D | 0.34541377 |
| 120 | SIK1 | 0.34323396 |
| 121 | MAP3K5 | 0.34083983 |
| 122 | PRKCQ | 0.33877792 |
| 123 | ACVR1B | 0.33789900 |
| 124 | ARAF | 0.33399367 |
| 125 | TESK2 | 0.33262286 |
| 126 | CDK9 | 0.32487671 |
| 127 | CDC7 | 0.31922287 |
| 128 | MAP2K2 | 0.29658739 |
| 129 | CDK19 | 0.29580559 |
| 130 | RAF1 | 0.28891591 |
| 131 | MAPK3 | 0.28721333 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.28493906 |
| 2 | Leishmaniasis_Homo sapiens_hsa05140 | 2.82006816 |
| 3 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.47638283 |
| 4 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.44725862 |
| 5 | DNA replication_Homo sapiens_hsa03030 | 2.35951215 |
| 6 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.32199547 |
| 7 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.27091030 |
| 8 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.21969826 |
| 9 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.17908988 |
| 10 | Other glycan degradation_Homo sapiens_hsa00511 | 2.15810846 |
| 11 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.14304201 |
| 12 | Measles_Homo sapiens_hsa05162 | 2.11996761 |
| 13 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.96025510 |
| 14 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.95306701 |
| 15 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.86514846 |
| 16 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.86011306 |
| 17 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.85484185 |
| 18 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.84353266 |
| 19 | Pertussis_Homo sapiens_hsa05133 | 1.82411962 |
| 20 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.79001778 |
| 21 | Tuberculosis_Homo sapiens_hsa05152 | 1.75857079 |
| 22 | Legionellosis_Homo sapiens_hsa05134 | 1.67025739 |
| 23 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.61531710 |
| 24 | Influenza A_Homo sapiens_hsa05164 | 1.59841808 |
| 25 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.58165878 |
| 26 | Malaria_Homo sapiens_hsa05144 | 1.57125183 |
| 27 | Base excision repair_Homo sapiens_hsa03410 | 1.55945361 |
| 28 | Allograft rejection_Homo sapiens_hsa05330 | 1.55526178 |
| 29 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.54428504 |
| 30 | Lysosome_Homo sapiens_hsa04142 | 1.49277028 |
| 31 | Mismatch repair_Homo sapiens_hsa03430 | 1.42470836 |
| 32 | Shigellosis_Homo sapiens_hsa05131 | 1.41861694 |
| 33 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.40105471 |
| 34 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.39818369 |
| 35 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.39575492 |
| 36 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.37175963 |
| 37 | Ribosome_Homo sapiens_hsa03010 | 1.36968973 |
| 38 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.33564335 |
| 39 | Apoptosis_Homo sapiens_hsa04210 | 1.32386085 |
| 40 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.29873462 |
| 41 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.22598467 |
| 42 | Homologous recombination_Homo sapiens_hsa03440 | 1.22587440 |
| 43 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.21514055 |
| 44 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.21441156 |
| 45 | Hepatitis B_Homo sapiens_hsa05161 | 1.19726828 |
| 46 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.16819101 |
| 47 | Asthma_Homo sapiens_hsa05310 | 1.16095937 |
| 48 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.09238671 |
| 49 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.05351313 |
| 50 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.04964872 |
| 51 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.04195078 |
| 52 | Salmonella infection_Homo sapiens_hsa05132 | 1.02534477 |
| 53 | Platelet activation_Homo sapiens_hsa04611 | 1.01083712 |
| 54 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.96864795 |
| 55 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.96180626 |
| 56 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.94958251 |
| 57 | Viral myocarditis_Homo sapiens_hsa05416 | 0.92511008 |
| 58 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.86771535 |
| 59 | Spliceosome_Homo sapiens_hsa03040 | 0.86596679 |
| 60 | Phagosome_Homo sapiens_hsa04145 | 0.85632453 |
| 61 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.79723773 |
| 62 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.79627115 |
| 63 | Hepatitis C_Homo sapiens_hsa05160 | 0.79359007 |
| 64 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.76792252 |
| 65 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.76272319 |
| 66 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.73994492 |
| 67 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.72843382 |
| 68 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.72557898 |
| 69 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.71654603 |
| 70 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.68923689 |
| 71 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.66140799 |
| 72 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.65554308 |
| 73 | HTLV-I infection_Homo sapiens_hsa05166 | 0.63889695 |
| 74 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.63516800 |
| 75 | Proteasome_Homo sapiens_hsa03050 | 0.62191973 |
| 76 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.61481890 |
| 77 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.60753972 |
| 78 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.58109682 |
| 79 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.56599427 |
| 80 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.56040064 |
| 81 | RNA polymerase_Homo sapiens_hsa03020 | 0.55339322 |
| 82 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.55249048 |
| 83 | Bladder cancer_Homo sapiens_hsa05219 | 0.54858292 |
| 84 | Cell cycle_Homo sapiens_hsa04110 | 0.53895467 |
| 85 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.51695400 |
| 86 | RNA degradation_Homo sapiens_hsa03018 | 0.50718830 |
| 87 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.50301292 |
| 88 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.49476795 |
| 89 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.46929316 |
| 90 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.46897378 |
| 91 | Colorectal cancer_Homo sapiens_hsa05210 | 0.44806540 |
| 92 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.44331748 |
| 93 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.44280805 |
| 94 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.43975213 |
| 95 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.43640271 |
| 96 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.42943448 |
| 97 | Endocytosis_Homo sapiens_hsa04144 | 0.42193156 |
| 98 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.42190565 |
| 99 | Amoebiasis_Homo sapiens_hsa05146 | 0.42121318 |
| 100 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.39999059 |
| 101 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.39726165 |
| 102 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.39141742 |
| 103 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.38862638 |
| 104 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.38791831 |
| 105 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.37465050 |
| 106 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.34388625 |
| 107 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.34370454 |
| 108 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.33345248 |
| 109 | Endometrial cancer_Homo sapiens_hsa05213 | 0.33237688 |
| 110 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.32976068 |
| 111 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.32660439 |
| 112 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.32607755 |
| 113 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.32141285 |
| 114 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.31578025 |
| 115 | Insulin resistance_Homo sapiens_hsa04931 | 0.31384016 |
| 116 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.31136819 |
| 117 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.30436417 |
| 118 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.30152513 |
| 119 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.28538749 |
| 120 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.28530247 |
| 121 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.27501067 |
| 122 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.27427915 |
| 123 | Prostate cancer_Homo sapiens_hsa05215 | 0.26454865 |
| 124 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.26125693 |
| 125 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.25624075 |
| 126 | Prion diseases_Homo sapiens_hsa05020 | 0.24818742 |
| 127 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.24305059 |

